Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03080974Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic AdenocarcinomaTreatment